83 FR 62326 - Evaluating the Therapeutic Potential of Cannabinoids: How To Conduct Research Within the Current Regulatory Framework

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 232 (December 3, 2018)

This workshop on December 8, 2018, sponsored by the National Center for Complementary and Integrative Health (NCCIH), a component of the National Institutes of Health (NIH), will bring together researchers, governmental officials, and industry representatives to discuss the processes and issues related to conducting cannabinoid research.

[Federal Register Volume 83, Number 232 (Monday, December 3, 2018)]
[Notices]
[Pages 62326-62327]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-26127]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Evaluating the Therapeutic Potential of Cannabinoids: How To 
Conduct Research Within the Current Regulatory Framework

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This workshop on December 8, 2018, sponsored by the National 
Center for Complementary and Integrative Health (NCCIH), a component of 
the National Institutes of Health (NIH), will bring together 
researchers, governmental officials, and industry representatives to 
discuss the processes and issues related to conducting cannabinoid 
research.

[[Page 62327]]


DATES: The meeting will be held on December 8, 2018, from 8:00 a.m. to 
5:30 p.m. (EST).

ADDRESSES: The meeting will be videocast. A link to the videocast will 
be posted on the NCCIH website, https://nccih.nih.gov/node/12170, once 
available.

FOR FURTHER INFORMATION CONTACT: For information concerning this 
meeting, see the NCCIH website, https://nccih.nih.gov/node/12170, or 
contract Dr. Angela Arensdorf, Science Policy Analyst, Office of 
Policy, Planning, and Evaluation, National Center for Complementary and 
Integrative Health, 9000 Rockville Pike, Building 31, Suite 2B11, 
Bethesda, MD 20892, telephone: 301-827-8277; email: 
[email protected].

SUPPLEMENTARY INFORMATION: This workshop will be an all-day meeting 
held on December 8, 2018 and will bring together representatives from 
the NIH, FDA, DEA, academia, and industry to discuss the issues related 
to conducting research with cannabinoids. The goals of this meeting are 
to gain an understanding of how to navigate this regulatory space, 
discuss future research opportunities, and foster collaborations. The 
focus of this workshop will be on the state of the science and working 
within current regulations. This meeting will NOT discuss challenging 
or changing current Federal laws, policies or regulations.

    Dated: November 23, 2018.
David Shurtleff,
Acting Director, National Center for Complementary and Integrative 
Health, National Institutes of Health.
[FR Doc. 2018-26127 Filed 11-30-18; 8:45 am]
BILLING CODE 4140-01-P